Besides, IGF2BP1-phase separation is associated with c-myc-mediated progression and proliferation in lung cancer cells mediated by MNX1-AS1, implying the MNX1-AS1/IGF2BP1 axis may serve as a potential biomarker and therapeutic target in NSCLC20. Here, IGF2BP1 is linked to lung cancer.